Navigation Links
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Date:3/6/2009

l showed a 55% mean reduction in inflammatory lesions and a 43% mean reduction in non-inflammatory lesions at Week 12. Furthermore, 39% of patients treated with Acanya Gel considered their moderate to severe acne to be 'clear' or 'almost clear' at Week 12, and importantly reported marked improvement as early as two weeks.

Tolerability: The incidence of adverse drug reactions was low and similar across all treatment groups. The majority (greater than or equal to 97%) were mild to moderate in severity. The following application-site adverse reactions occurred in less than 0.2% of patients treated with Acanya Gel: application-site pain (0.1%), application-site exfoliation (0.1%), and application-site irritation (0.1%). Given the potential for skin irritation with fixed combination products containing higher concentrations (>2.5%) of BPO, no patient on Acanya discontinued treatment because of local signs or symptoms of stinging, burning, itching, erythema, or scaling, and in no patient were these severe. Mean scores for each local sign/symptom were <1 (1=mild) and comparable to individual active ingredients and vehicle.

Patient Satisfaction: Patient satisfaction data collected in the Phase III program showed significantly greater mean satisfaction scores with Acanya Gel at Week 12 than with prior acne therapy. Indeed 81% of patients were 'satisfied' with Acanya Gel at the end of treatment.

Acne: Widespread Condition

Acne vulgaris is a common skin disorder affecting 40 to 50 million Americans, or about 85 percent of people, at some point in their lives. The disorder is thought to be caused by multiple factors. Overproduction of sebum, a normal oily substance on the skin surface, combined with dead skin cells that are abnormally shed from the hair follicle, lead to plugging of the follicle. This allows skin bacteria, Propionibacterium acnes, to multiply and cause inflammat
'/>"/>

SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Optimer Pharmaceuticals, Inc. (Nasdaq: ... the 28th Annual J.P. Morgan Healthcare Conference at ... on Wednesday, January 13, 2010. Michael N. Chang, ... at 2:30 p.m. Pacific Time (5:30 p.m. Eastern ... live audio webcast of this presentation will be ...
(Date:12/16/2009)... 16 Advanced Life Sciences Holdings, Inc. ... results from a pivotal, non-human primate study of ... an inhaled lethal dose of tularemia. A 14-day ... at the doses tested. All of the ... mg/kg once-a-day of Restanza (approximate to a human ...
(Date:12/15/2009)... -- Warner Chilcott plc (Nasdaq: WCRX ) ... (the "Company") has commenced a cash tender offer, ... set forth in the Company,s Offer to Purchase ... (the "Offer to Purchase"), for any and all ... 2015 (the "Notes"). ,, The Company is also ...
Breaking Medicine Technology:Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 48273 1Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 48273 2Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 48273 3Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 48273 4Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 48273 5DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 48270 1DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 48270 2DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 48270 3Canary Foundation and Stanford University Commit 2420 Million for World Class Research Center for Cancer Early Detection 48267 1Canary Foundation and Stanford University Commit 2420 Million for World Class Research Center for Cancer Early Detection 48267 2Canary Foundation and Stanford University Commit 2420 Million for World Class Research Center for Cancer Early Detection 48267 3
(Date:12/16/2009)... - TSO3 Inc. ("TSO3") (TSX: TOS) and 3M ... reached for 3M to be the exclusive supplier ... partnership with TSO3, an innovator in low temperature ... through the use of ozone, will include new ... global sales channel. This agreement, combined with recent ...
(Date:12/16/2009)... being presented with the Weatherhead 100 Upstart Award on December 3, ... Northeast Ohio and is a testament to hard work, commitment, innovation ... ... (PRWEB) December 16, 2009 -- Request A Test, Ltd. is ... on December 3, 2009. The Weatherhead 100 showcases the fastest ...
(Date:12/16/2009)... have announced a great addition to one of the most ... website at www.hallmark.co.uk/specialoccasions , customers can now personalise just about ... photos and then order as many copies of their design with ... ... December 16, 2009 -- Just in time for the Christmas rush ...
(Date:12/16/2009)... Help Hair Shake in all of the Florida Whole Foods store. ... ... Dr. Larry Shapiro, hair transplant and hair loss physician , is ... Help Hair Whey Protein Shake. Dr. Shapiro developed the all natural ... loss programs, working out and muscle building., , , , ,The Whole ...
(Date:12/15/2009)... The failure of the U.S. Senate ... costs, much less the more effective direct bulk ... example of how big industry controls the health ... drug amendment by Senator Dorgan (D-ND) was a ... pledge to allow Medicare to directly negotiate discounts ...
Breaking Medicine News(10 mins):Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3
... in the US are worried about yet another bout of ... ,Rudy Bueno, the Chief of Mosquito Control of the ... people don't follow the precautionary measures. There is still a ... been affected by this disease. Not using repellants or going ...
... of Hurricane Katrina in New Orleans are still struggling ... be having the lions share of this. ,Accordingly, more ... the disaster said they had money problems because of the hurricane ... job or had to take a lower-paying job. The study ...
... Ridge, Ill. "Every second counts for anesthesia patients afflicted ... hyperthermia (MH)." According to research published in the ... Anesthetists, the intravenous administration of life-saving dantrolene sodium (DS) ... of warming the diluent that is used to prepare ...
... young women-under 55 is an aggressive disease that has to ... at the American Heart Association's (AHA) scientific forum on Quality ... in Washington, D.C., says that women under the age ... heart attack until it's too late. ,Ignoring those ...
... than 10 a week in spending money and who buy ... drinkers', a survey of over 10,000 teenagers reveals. ... studied the results of an alcohol questionnaire given anonymously to ... admitted to drinking alcohol, of which 38% binged, 24% drank ...
... per cent) of British women and a quarter of British men ... a result of excessive exposure to the sun, according to a ... highlight Sun Awareness Week, which kicks off Monday 7 May. ... meant that one in three Brits could not wear the clothes ...
Other Medicine News:Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Hurricane Katrina Still Wrecking Lives - More So With Blacks 2Health News:Research Reveals Way to Speed Up Treatment of Deadly Malignant Hyperthermia 2Health News:Younger Women At Risk Of Heart Disease 2Health News:Younger Women At Risk Of Heart Disease 3Health News:Burnt Brits Don't Feel Hot 2
US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control...
3.0% Tryptone, 2.0% Yeast Extract, 1.0% MOPS free acid, 2.0% Glucose....
0.3% Beef extract, 0.5% Peptone, 0.5 % Lactose....
... The user-friendly Eppendorf Thermomixer R offers ... that require shaking, heating, and cooling. ... expanded its application and temperature control ... each accommodate 24 micro test tubes, ...
Medicine Products: